Objectives
After participating in this educational activity, attendees should be able to:
- Describe mechanism of action of methotrexate.
- Identify 3 potential toxicities of methotrexate.
- Discuss management of methotrexate neurotoxicity.
- Recognize signs and symptoms of transient myeloproliferative disorder.
- Explain the relationship between TMD and trisomy 21.
Faculty
Matthew Richardson, MD
Assistant Professor of Pediatrics
University of Massachusetts Medical School-Baystate
Joanna Luty, MD
Assistant Professor of Pediatrics
University of Massachusetts Medical School-Baystate
Commercial Relationships: None
Session date:
09/04/2018 - 8:00am to 9:00am EDT
Location:
Baystate Medical Center
759 Chestnut Street
Chestnut 1 A & B
Springfield, MA
01199
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 BCIPE Instructional Hours